Validated technology in peer-reviewed studies

Proven technology

We’re reshaping the future of respiratory care with simple and accurate technology that can be used by physicians and patients alike. Our technology has been validated in peer-reviewed studies.

Clinical Studies and Evidence

Pilot study with Royal Brompton Hospital suggests NuvoAir platform may improve Cystic Fibrosis outcomes (2019)

200 patient study at Tygerberg Academic Hospital, Cape Town, South Africa validates NuvoAir spirometry technology (2019)

200 patient study at University Hospital Complex of Vigo, Spain validates NuvoAir spirometry technology (2018)

NuvoAir technology supports 26 300 COPD patient study in Germany (2019)

NuvoAir technology chosen for lung function monitoring in ALS study (2019)

200 patient study validates Air Next against Gold standard spirometry (2019)

Validation of Air Next spirometer in patients with different respiratory diseases (2020)

Air Next supports Kazakhstan Academy of Preventive Medicine in assessing lung function changes in a COPD patient population (2020)

NuvoAir Reduced Booked and Urgent Face to Face Consultations in Cystic Fibrosis Patients (2020)